Hepatic Removal Kinetics: Importance for Quantitative Measurements of Liver Function

Textbook of Hepatology: From Basic Science to Clinical Practice, Third Edition

Volumn , Issue , 2008, Pages 468-478

  Keiding, Susanne ^a   Sørensen, Michael ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Blood concentration; Caffeine; Hepatocytes; Microcirculation; Sinusoids

Indexed keywords

EID: 84889413413     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470691861.ch5c     Document Type: Chapter

References (107)

1. Tygstrup N. (1990) Assessment of liver function: principles and practice. J Gastroenterol Hepatol 5, 468-482.
2. Bass L, Keiding S, Winkler K et al. (1976) Enzymatic elimination of substrates flowing through the intact liver. J Theor Biol 61, 393-409.
3. Keiding S, Johansen S, Winkler K et al. (1976) Michaelis-Menten kinetics of galactose elimination by the isolated perfused pig liver. Am J Physiol 230, 1302-1313.
4. Keiding S, Chiarantini E. (1978) Effect of sinusoidal perfusion on galactose elimination kinetics in perfused rat liver. J Pharmacol Exp Ther 205, 465-470.
5. Keiding S, Priisholm K. (1984) Current models of hepatic pharmacokinetics: flow effects on kinetic constants of ethanol elimination in perfused rat liver. Biochem Pharmacol 33, 3209-3212.
6. Keiding S, Skak C. (1988) Methodological limitations of the use of intrinsic hepatic clearance of ICG as a measure of liver cell function. Eur J Clin Invest 18, 507-511.
7. Krarup N, Larsen JA. (1976) The influence of dye infusion rate and hepatic plasma flow on indocyanine green clearance. Scand J Clin Lab Invest 36, 183-188.
8. Greenway CV, Burczynski FJ. (1987) Effects of liver blood flow on hepatic uptake kinetics of galactose in anesthetized cats: parallel tube model. Can J Physiol Pharmacol 65, 1193-1199.
9. Keiding S, Johansen S, Winkler K. (1982) Hepatic galactose elimination kinetics in the intact pig. Scand J Clin Lab Invest 42, 253-259.
10. Keiding S, Johansen S, Midtboll I et al. (1979) Ethanol elimination kinetics in human liver and pig liver in vivo. Am J Physiol 237, E316-E324.
11. Andreasen B, Tonnesen K, Rabol A et al. (1977) Michaelis-Menten kinetics of phenazone elimination in the perfused pig liver. Acta Pharmacol Toxicol 40, 1-13.
12. D'Amour P, Huet PM. (1989) Ca2+ concentration influences the hepatic extraction of bioactive human PTH-(1-34) in rats. Am J Physiol 256, E87-E92.
13. Jacobsen KR, Ranek L, Tygstrup N. (1969) Liver function and blood flow in normal man during infusion of vasopressin. Scand J Clin Lab Invest 24, 279-284.
14. Tygstrup N. (1977) Effect of sites of blood sampling in determination of the galactose elimination capacity. Scand J Clin Lab Invest 37, 333-338.
15. Tygstrup N. (1966) Determination of the hepatic elimination capacity (Lm) of galactose by single injection. Scand J Clin Lab Invest Suppl 18, 118-125.
16. Ranek L, Andreasen PB, Tygstrup N. (1976) Galactose elimination capacity as a prognostic index in patients with fulminant liver failure. Gut 17, 959-964.
17. Merkel C, Bolognesi M, Angeli P et al. (1989) Prognostic indicators of survival in patients with cirrhosis and esophageal varices, without previous bleeding. Am J Gastroenterol 84, 717-722.
18. Merkel C, Gatta A, Zoli M et al. (1991) Prognostic value of galactose elimination capacity, aminopyrine breath test, and ICG clearance in patients with cirrhosis. Comparison with the Pugh score. Dig Dis Sci 36, 1197-1203.
19. Merkel C, Marchesini G, Fabbri A et al. (1996) The course of galactose elimination capacity in patients with alcoholic cirrhosis: possible use as a surrogate marker for death. Hepatology 24, 820-823.
20. Jepsen P, Vilstrup H, Sørensen HT et al. (2004) Galactose elimination capacity and prognosis of patients with liver cirrhosis-a Danish registry-based cohort study with complete long-term follow-up. J Hepatol 40 (Suppl. 1), 69A.
21. Vilstrup H. (1980) Synthesis of urea after stimulation with amino acids: relation to liver function. Gut 21, 990-995.
22. Hamberg O, Vilstrup H. (1994) A rapid method for determination of hepatic amino nitrogen to urea nitrogen conversion ('the Functional Hepatic Nitrogen Clearance'). Scand J Clin Lab Invest 54, 377-383.
23. Hamberg O, Nielsen K, Vilstrup H. (1992) Effects of an increase in protein intake on hepatic efficacy for urea synthesis in healthy subjects and in patients with cirrhosis. J Hepatol 14, 237-243.
24. Grofte T, Wolthers T, Jorgensen JO et al. (1999) Hepatic amino-to urea-N clearance and forearm amino-N exchange during hypoglycemic and euglycemic hyperinsulinemia in normal man. J Hepatol 30, 819-825.
25. Crone C. (1963) The permeability of capillaries in various organs as determined by use of the 'indicator dilution' method. Acta Physiol Scand 58, 292-305.
26. Keiding S, Johansen S, Tygstrup N. (1990) Galactose removal kinetics during hypoxia in perfused pig liver: reduction of Vmax, but not of intrinsic clearance Vmax/Km. Eur J Clin Invest 20, 305-309.
27. Winkler K, Bass L, Keiding S et al. (1979) The physiologic basis for clearance measurements in hepatology. Scand J Gastroenterol 14, 439-448.
28. Keiding S. (1976) Hepatic elimination kinetics: the influence of hepatic blood flow on clearance determination. Scand J Clin Lab Invest 36, 113-118.
29. Bonati M, Latini R, Galletti F et al. (1982) Caffeine disposition after oral doses. Clin Pharmacol Ther 32, 98-106.
30. Renner E, Wietholtz H, Huguenin P et al. (1984) Caffeine: a model compound for measuring liver function. Hepatology 4, 38-46.
31. Wilkinson GR, Shand DG. (1975) Commentary: a physiological approach to hepatic drug clearance. Clin Pharmacol Ther 18, 377-390.
32. Andreasen PB, Ranek L, Statland BE et al. (1974) Clearance of antipyrine-dependence of quantitative liver function. Eur J Clin Invest 4, 129-134.
33. Buters JT, Zysset T, Reichen J. (1993) Metabolism of antipyrine in vivo in two rat models of liver cirrhosis. Its relationship to intrinsic clearance in vitro and microsomal membrane lipid composition. Biochem Pharmacol 46, 983-991.
34. Skak C, Keiding S. (1987) Methodological problems in the use of indocyanine green to estimate hepatic blood flow and ICG clearance in man. Liver 7, 155-162.
35. Keiding S, Engsted E, Ott P. (1998) Sorbitol as a test substance for measurements of liver plasma flow in humans. Hepatology 28, 50-56.
36. Molino G, Avagnina P, Ballare M et al. (1991) Combined evaluation of total and functional liver plasma flows and intrahepatic shunting. Dig Dis Sci 36, 1189-1196.
37. Ott P, Clemmesen O, Keiding S. (2000) Interpretation of simultaneous measurements of hepatic extraction fractions of indocyanine green and sorbitol: evidence of hepatic shunts and capillarization? Dig Dis Sci 45, 359-365.
38. Zeeh J, Lange H, Bosch J et al. (1988) Steady-state extrarenal sorbitol clearance as a measure of hepatic plasma flow. Gastroenterology 95, 749-759.
39. Henderson JM, Kutner MH, Bain RP. (1982) First-order clearance of plasma galactose: the effect of liver disease. Gastroenterology 83, 1090-1096.
40. Keiding S. (1988) Galactose clearance measurements and liver blood flow. Gastroenterology 94, 477-481.
41. Munk OL, Bass L, Roelsgaard K et al. (2001) Liver kinetics of glucose analogs measured in pigs by PET: importance of dual-input blood sampling. J Nucl Med 42, 795-801.
42. Brix G, Ziegler SI, Bellemann ME et al. (2001) Quantification of [(18)F]FDG uptake in the normal liver using dynamic PET: impact and modeling of the dual hepatic blood supply. J Nucl Med 42, 1265-1273.
43. Keiding S, Munk OL, Schiott KM et al. (2000) Dynamic 2-[18F]fluoro-2-deoxy-d-glucose positron emission tomography of liver tumours without blood sampling. Eur J Nucl Med 27, 407-412.
44. Munk OL, Keiding S, Bass L. (2003) Impulse-response function of splanchnic circulation with model-independent constraints: theory and experimental validation. Am J Physiol Gastrointest Liver Physiol 285, G671-G680.
45. Munk OL. (2005) Hepatic metabolism of glucose analogs measured by dynamic positron emission tomography and interpreted by compartment models. PhD thesis, Faculty of Health Sciences, University of Aarhus, Denmark.
46. Gjedde A. (1982) Calculation of cerebral glucose phosphorylation from brain uptake of glucose analogs in vivo: a re-examination. Brain Res 257, 237-274.
47. Patlak CS, Blasberg RG. (1985) Graphical evaluation of bloodto-brain transfer constants from multiple-time uptake data. Generalizations. J Cereb Blood Flow Metab 5, 584-590.
48. Keiding S, Hansen SB, Rasmussen HH et al. (1998) Detection of cholangiocarcinoma in primary sclerosing cholangitis by positron emission tomography. Hepatology 28, 700-706.
49. Prytz H, Keiding S, Björnsson E et al. (2006) Dynamic FDG PET is useful for detection of cholangiocarcinoma in patients with PSC listed for liver transplantation. Hepatology 44, 1572-1580.
50. Germano G, Chen BC, Huang SC et al. (1992) Use of the abdominal aorta for arterial input function determination in hepatic and renal PET studies. J Nucl Med 33, 613-620.
51. Munk OL, Keiding S. (2002) Quantification of (18)F-FDG uptake in the liver using dynamic PET. J Nucl Med 43, 439-441.
52. Becker G, Müller-Schauenburg W, Spilker ME et al. (2005) A priori identifiability of a one-compartment model with two input functions for liver blood flow measurements. Phys Med Biol 50, 1393-1404.
53. Munk OL, Keiding S, Bass L. (2003) Capillaries within compartments: microvascular interpretation of dynamic positron emission tomography data. J Theor Biol 225, 127-141.
54. Munk OL, Bass L, Feng H et al. (2003) Determination of regional flow by use of intravascular PET tracers: microvascular theory and experimental validation for pig livers. J Nucl Med 44, 1862-1870.
55. Sørensen M, Keiding S. (2006) Ammonia metabolism in cirrhosis. In: Häussinger D, Kircheisi G, Schless F (eds) Proceedings of the 12th International Symposium of Hepatic Encephalopathy and Nitrogen Metabolism. Springer Verlag, pp. 406-419.
56. Keiding S, Sørensen M, Bender D et al. (2006) Brain metabolism of 13N-ammonia during acute hepatic encephalopathy in cirrhosis measured by PET. Hepatology 43, 42-50.
57. Haussinger D, Stoll B, Stehle T et al. (1989) Hepatocyte heterogeneity in glutamate metabolism and bidirectional transport in perfused rat liver. Eur J Biochem 185, 189-195.
58. Stoll B, McNelly S, Buscher HP et al. (1991) Functional hepatocyte heterogeneity in glutamate, aspartate and alpha-ketoglutarate uptake: a histoautoradiographical study. Hepatology 13, 247-253.
59. Gumucio JJ. (1989) Hepatocyte heterogeneity: the coming of age from the description of a biological curiosity to a partial understanding of its physiological meaning and regulation. Hepatology 9, 154-160.
60. Haussinger D, Lamers WH, Moorman AF. (1992) Hepatocyte heterogeneity in the metabolism of amino acids and ammonia. Enzyme 46, 72-93.
61. Keiding S, Munk OL, Roelsgaard K et al. (2001) Positron emission tomography of hepatic first-pass metabolism of ammonia in pig. Eur J Nucl Med 28, 1770-1775.
62. Lautt WW, Schafer J, Legare DJ. (1993) Hepatic blood flow distribution: consideration of gravity, liver surface, and norepinephrine on regional heterogeneity. Can J Physiol Pharmacol 71, 128-135.
63. Bass L, Robinson P, Bracken AJ. (1978) Hepatic elimination of flowing substrates: the distributed model. J Theor Biol 72, 161-184.
64. Richter S, Vollmar B, Mucke I et al. (2001) Hepatic arteriolo-portal venular shunting guarantees maintenance of nutritional microvascular supply in hepatic arterial buffer response of rat livers. J Physiol 531, 193-201.
65. Keiding S, Munk OL, Vilstrup H et al. (2005) Hepatic microcirculation assessed by positron emission tomography of first-pass ammonia metabolism in porcine liver. Liver Int 25, 171-176.
66. Keiding S, Vilstrup H. (2002) Intrahepatic heterogeneity of hepatic venous pressure gradient in human cirrhosis. Scand J Gastroenterol 37, 960-964.
67. Hansen HJ, Engell HC, Ring-Larsen H et al. (1977) Splanchnic blood flow in patients with abdominal angina before and after arterial reconstruction. A proposal for a diagnostic test. Ann Surg 186, 216-220.
68. Keiding S, Vilstrup H, Hansen L. (1980) Importance of flow and haematocrit for metabolic function of perfused rat liver. Scand J Clin Lab Invest 40, 355-359.
69. Brauer RW. (1963) Liver circulation and function. Physiol Rev 43, 115-213.
70. Lautt WW. (1977) Hepatic vasculature: a conceptual review. Gastroenterology 73, 1163-1169.
71. Keiding S. (1995) Drug administration to liver patients: aspects of liver pathophysiology. Semin Liver Dis 15, 268-282.
72. Levy G. (1965) Pharmacokinetics of salicylate elimination in man. J Pharm Sci 54, 959-967.
73. Forker EL, Luxon BA. (1983) Albumin-mediated transport of rose bengal by perfused rat liver. Kinetics of the reaction at the cell surface. J Clin Invest 72, 1764-1771.
74. Ott P, Keiding S, Bass L. (1992) Intrinsic hepatic clearance of indocyanine green in the pig: dependence on plasma protein concentration. Eur J Clin Invest 22, 347-357.
75. Weisiger RA, Zacks CM, Smith ND et al. (1984) Effect of albumin binding on extraction of sulfobromophthalein by perfused elasmobranch liver: evidence for dissociation-limited uptake. Hepatology 4, 492-501.
76. Weisiger RA. (1985) Dissociation from albumin: a potentially ratelimiting step in the clearance of substances by the liver. Proc Natl Acad Sci USA 82, 1563-1567.
77. Keiding S, Ott P, Bass L. (1993) Enhancement of unbound clearance of ICG by plasma proteins, demonstrated in human subjects and interpreted without assumption of facilitating structures. J Hepatol 19, 327-344.
78. Sorrentino D, Licko V, Weisiger RA et al. (1987) Phenobarbital specifically increases the hepatocellular uptake of sulfobromophthaleinglutathione. Biochem Biophys Res Commun 149, 921-926.
79. Bass L, Keiding S. (1988) Physiologically based models and strategic experiments in hepatic pharmacology. Biochem Pharmacol 37, 1425-1431.
80. Pond S, Bass L. (1988) The puzzle of rates of cellular uptake of protein-bound ligands. In: Pecile A, Rescigno A (eds) Pharmacokinetics: Mathematical Approaches to Metabolism and Distribution of Chemicals and Drugs. New York, London: Plenum Publishing, pp. 245-269.
81. Ott P, Weisiger RA. (1997) Nontraditional effects of protein binding and hematocrit on uptake of indocyanine green by perfused rat liver. Am J Physiol 273, G227-G238.
82. Weisiger RA, Pond SM, Bass L. (1989) Albumin enhances unidirectional fluxes of fatty acid across a lipid-water interface: theory and experiments. Am J Physiol 257, G904-G916.
83. Nijssen HM, Pijning T, Meijer DK et al. (1992) Influence of albumin on the net sinusoidal efflux of the organic anion dibromosulfophthalein from rat liver. Hepatology 15, 302-309.
84. Tygstrup N. (1964) The galactose elimination capacity in relation to clinical and laboratory findings in patients with cirrhosis. Acta Med Scand 175, 291-300.
85. Reichen J, Widmer T, Cotting J. (1991) Accurate prediction of death by serial determination of galactose elimination capacity in primary biliary cirrhosis: a comparison with the Mayo model. Hepatology 14, 504-510.
86. Popper H, Elias H, Petty DE. (1952) Vascular pattern of the cirrhotic liver. Am J Clin Pathol 22, 717-729.
87. Huet PM, Goresky CA, Villeneuve JP et al. (1982) Assessment of liver microcirculation in human cirrhosis. J Clin Invest 70, 1234-1244.
88. Sugano S, Yamamoto K, Takamura N et al. (1999) Azygos venous blood flow while fasting, postprandially, and after endoscopic variceal ligation, measured by magnetic resonance imaging. J Gastroenterol 34, 310-314.
89. Bendtsen F, Henriksen JH, Sorensen TI. (1991) Long-term effects of oral propranolol on splanchnic and systemic haemodynamics in patients with cirrhosis and oesophageal varices. Scand J Gastroenterol 26, 933-939.
90. Ramsoe K, Andreasen PB, Ranek L. (1980) Functioning liver mass in uncomplicated and fulminant acute hepatitis. Scand J Gastroenterol 15, 65-72.
91. Schmidt LE, Ott P, Tygstrup N. (2004) Galactose elimination capacity as a prognostic marker in patients with severe acetaminophen-induced hepatotoxicity: 10 years' experience. Clin Gastroenterol Hepatol 2, 418-424.
92. Saunders JB, Wright N, Lewis KO. (1980) Predicting outcome of paracetamol poisoning by use of 14C-aminopyrine breath test. Br Med J 280, 279-280.
93. Schneider JF, Baker AL, Haines NW et al. (1980) Aminopyrine N-demethylation: a prognostic test of liver function in patients with alcoholic liver disease. Gastroenterology 79, 1145-1150.
94. Merkel C, Bolognesi M, Finucci GF et al. (1989) Indocyanine green intrinsic hepatic clearance as a prognostic index of survival in patients with cirrhosis. J Hepatol 9, 16-22.
95. Merkel C, Bolognesi M, Bellon S et al. (1992) Aminopyrine breath test in the prognostic evaluation of patients with cirrhosis. Gut 33, 836-842.
96. Merkel C, Morabito A, Sacerdoti D et al. (1998) Updating prognosis of cirrhosis by Cox's regression model using Child-Pugh score and aminopyrine breath test as time-dependent covariates. Ital J Gastroenterol Hepatol 30, 276-282.
97. Villeneuve JP, Infante-Rivard C, Ampelas M et al. (1986) Prognostic value of the aminopyrine breath test in cirrhotic patients. Hepatology 6, 928-931.
98. Lashner BA, Jonas RB, Tang HS et al. (1988) Chronic hepatitis: disease factors at diagnosis predictive of mortality. Am J Med 85, 609-614.
99. Redaelli CA, Dufour JF, Wagner M et al. (2002) Preoperative galactose elimination capacity predicts complications and survival after hepatic resection. Ann Surg 235, 77-85.
100. Jansen PL, Chamuleau RA, van Leeuwen DJ et al. (1990) Liver regeneration and restoration of liver function after partial hepatectomy in patients with liver tumors. Scand J Gastroenterol 25, 112-118.
101. Bender H, Bangard N, Metten N et al. (1999) Possible role of FDGPET in the early prediction of therapy outcome in liver metastases of colorectal cancer. Hybridoma 18, 87-91.
102. Dimitrakopoulou-Strauss A, Strauss LG, Rudi J. (2003) PET-FDG as predictor of therapy response in patients with colorectal carcinoma. Q J Nucl Med 47, 8-13.
103. Antoch G, Kaiser GM, Mueller AB et al. (2004) Intraoperative radiation therapy in liver tissue in a pig model: monitoring with dualmodality PET/CT. Radiology 230, 753-760.
104. Antoch G, Vogt FM, Veit P et al. (2005) Assessment of liver tissue after radiofrequency ablation: findings with different imaging procedures. J Nucl Med 46, 520-525.
105. Poulsen HE, Loft S. (1988) Antipyrine as a model drug to study hepatic drug-metabolizing capacity. J Hepatol 6, 374-382.
106. Bircher J, Kupfer A, Gikalov I et al. (1976) Aminopyrine demethylation measured by breath analysis in cirrhosis. Clin Pharmacol Ther 20, 484-492.
107. Lauterburg BH, Liang D, Schwarzenbach FA et al. (1993) Mitochondrial dysfunction in alcoholic patients as assessed by breath analysis. Hepatology 17, 418-422.